Glen D. Stettin

Glen D. Stettin

Director/Board Member at MEDAVAIL HOLDINGS, INC.

Net worth: - $ as of 2024-02-28

60 year
Consumer Services
Retail Trade
Commercial Services

Profile

Glen D.
Stettin
is an Independent Director at MedAvail Holdings, Inc., and a Senior VP at Express Scripts, Inc. He is also the Chief Innovation Officer & Senior VP-Research at Express.
Scripts Holding Co. Stettin has previously served as an Independent Director at PRA Health Sciences, Inc., a Director at MedAvail, Inc., and as the Chief Medical Officer & Senior Vice President at Medco Health Solutions, Inc. Stettin holds an undergraduate degree from Lehigh University and a doctorate from Drexel University College of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-14 0 ( -.--% ) - $ 2024-02-28

Glen D. Stettin active positions

CompaniesPositionStart
EXPRESS SCRIPTS HOLDING CO Corporate Officer/Principal 2012-03-31
MEDAVAIL HOLDINGS, INC. Director/Board Member 2020-11-17
Chief Tech/Sci/R&D Officer 2012-07-04
All active positions of Glen D. Stettin

Former positions of Glen D. Stettin

CompaniesPositionEnd
Director/Board Member 2022-01-31
PRA HEALTH SCIENCES, INC. Director/Board Member 2021-06-30
Chief Tech/Sci/R&D Officer 2012-03-31
See the detail of Glen D. Stettin's experience

Training of Glen D. Stettin

Lehigh University Undergraduate Degree
Drexel University College of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Glen D. Stettin's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
MEDAVAIL HOLDINGS, INC.

Health Technology

Private companies5

Retail Trade

Commercial Services

Health Services

Finance

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Glen D. Stettin